Cargando…
Clinicopathological Features and Treatment Challenges in Triple Negative Breast Cancer Patients: A Retrospective Cohort Study
Objective: As the genetic and molecular profiles of triple negative breast carcinoma (TNBC) are elucidated, multiple therapeutic targets have been produced. TNBC with less than 1% androgen receptor (AR) expression may respond to enzalutamide with greater response association in higher levels. A metr...
Autores principales: | Elwan, Amira, Abdelrahman, Aziza E., Alnagar, Ahmed A., Abdelhamid, Mohamed I, Nawar, Nashwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Federation of Turkish Pathology Societies
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512684/ https://www.ncbi.nlm.nih.gov/pubmed/33432555 http://dx.doi.org/10.5146/tjpath.2020.01516 |
Ejemplares similares
-
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016) -
Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features
por: Derkaoui, Touria, et al.
Publicado: (2016) -
Clinicopathologic features of triple negative breast cancers: an experience from Pakistan
por: Hashmi, Atif Ali, et al.
Publicado: (2014) -
The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer
por: Liao, Hong-Ye, et al.
Publicado: (2018) -
Triple-negative invasive breast carcinoma: the association between the sonographic appearances with clinicopathological feature
por: Li, Jia-wei, et al.
Publicado: (2018)